US5836705A
(en)
*
|
1992-07-27 |
1998-11-17 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and data entry and to ease transition from a qwerty keyboard
|
US5498088A
(en)
*
|
1992-07-27 |
1996-03-12 |
Choate; John I. M. |
Keyboard arrangement to maximize typing speed and ease of transition from a qwerty keyboard
|
US5352050A
(en)
*
|
1992-07-27 |
1994-10-04 |
Choate John I M |
Keyboard arrangement to maximize typing speed and ease of transition from a QWERTY keyboard
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
YU18596A
(sh)
*
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
DE69630527T2
(de)
*
|
1995-06-30 |
2004-08-05 |
Novo Nordisk A/S |
Vorbeugung einer krankheit mit diabetes charakter
|
AU720484B2
(en)
*
|
1996-06-20 |
2000-06-01 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
CO4750643A1
(es)
*
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
HUP0004169A3
(en)
|
1997-10-24 |
2001-06-28 |
Lilly Co Eli |
Insoluble insulin compositions and process for production thereof
|
CO4970787A1
(es)
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
EP1044016B1
(en)
*
|
1998-01-09 |
2005-03-16 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
US6635617B1
(en)
|
1998-10-16 |
2003-10-21 |
Novo Nordisk A/S |
Insulin preparations for pulmonary delivery containing menthol
|
US6211144B1
(en)
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
WO2000023098A1
(en)
*
|
1998-10-16 |
2000-04-27 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
ATE216258T1
(de)
*
|
1998-10-16 |
2002-05-15 |
Novo Nordisk As |
Insulin präparationen enthaltend methanol zur pulmonaren verabreichung
|
DE69914934T2
(de)
*
|
1998-11-18 |
2005-01-05 |
Novo Nordisk A/S |
Stabile, wässrige insulin-präparate ohne phenol und cresol
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
US20040214747A1
(en)
*
|
1999-01-06 |
2004-10-28 |
Dimarchi Richard Dennis |
Method for administering monomeric insulin
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
AU2001284364B2
(en)
*
|
2000-07-31 |
2006-09-28 |
Bar Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
DE10114178A1
(de)
*
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
EP2272501B1
(en)
|
2002-01-09 |
2013-03-20 |
Emisphere Technologies, Inc. |
Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
|
US20030211976A1
(en)
*
|
2002-03-07 |
2003-11-13 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin formulation
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
US20060258561A1
(en)
*
|
2003-03-13 |
2006-11-16 |
Novo Nordisk A/S |
Novel NPH insulin preparations
|
DK1633876T3
(da)
|
2003-06-17 |
2008-12-08 |
Sembiosys Genetics Inc |
Fremgangsmåde til fremstilling af insulin i planter
|
SI1648933T1
(sl)
*
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Dolgo delujoäś inzulinski derivat in metoda zanj
|
AU2005209199B2
(en)
*
|
2004-01-16 |
2008-09-11 |
Biodel Inc. |
Sublingual drug delivery device
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
CN102040535B
(zh)
|
2004-05-06 |
2012-10-17 |
爱密斯菲尔科技公司 |
N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶
|
WO2005117854A2
(en)
*
|
2004-05-14 |
2005-12-15 |
Emisphere Technologies, Inc. |
Aryl ketone compounds and compositions for delivering active agents
|
WO2005115341A2
(en)
*
|
2004-05-27 |
2005-12-08 |
Advanced Bionutrition Corporation |
Microparticles for oral delivery
|
BRPI0513508B1
(pt)
|
2004-07-19 |
2021-06-01 |
Biocon Limited |
Conjugados de insulina-oligômero, formulações e usos desses
|
US20100048454A1
(en)
*
|
2004-08-03 |
2010-02-25 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
JP2008509933A
(ja)
*
|
2004-08-13 |
2008-04-03 |
エミスフェアー・テクノロジーズ・インク |
送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
|
CN102772788B
(zh)
*
|
2004-10-05 |
2017-06-06 |
诺和诺德公司 |
包含结晶的胰岛素和溶解的胰岛素的药物制剂
|
CN101060856B
(zh)
|
2004-11-22 |
2011-01-19 |
诺和诺德公司 |
可溶、稳定的含胰岛素制剂
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
EP1862174A1
(en)
*
|
2005-03-02 |
2007-12-05 |
Ajinomoto Co., Inc. |
Inhibitor for insulin polymer formation
|
EP2462944A3
(en)
|
2005-08-29 |
2012-09-12 |
HealOr Ltd. |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
AR058053A1
(es)
|
2005-09-19 |
2008-01-23 |
Toole Doris C O |
Formas cristalinas polimorficas de la sal de di- sodio del acido n- (5 -clorosaliciloil)-8- aminocaprilico
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20090069216A1
(en)
*
|
2006-02-21 |
2009-03-12 |
Novo Nordisk A/S |
Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
|
CA2649109A1
(en)
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007121318A2
(en)
|
2006-04-12 |
2007-10-25 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
EP2134351B1
(en)
|
2007-03-13 |
2016-04-27 |
Nutrition 21, Inc. |
Methods and compositions for the sustained release of chromium
|
EP2136624A4
(en)
*
|
2007-03-21 |
2011-11-30 |
Emisphere Tech Inc |
ALLYLOXY AND ALKYLOXY BENZOIC ACID DELIVERY AGENTS
|
EP2152243A2
(en)
*
|
2007-04-30 |
2010-02-17 |
Novo Nordisk A/S |
Highly concentrated insulin solutions and compositions
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
WO2009059188A1
(en)
|
2007-11-02 |
2009-05-07 |
Emisphere Technologies, Inc. |
Method of treating vitamin b12 deficiency
|
KR20110061552A
(ko)
|
2008-07-31 |
2011-06-09 |
케이스 웨스턴 리저브 유니버시티 |
할로겐 안정화된 인슐린
|
EP2337563B1
(en)
|
2008-09-08 |
2014-04-09 |
The Board of Trustees of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
PT2349324T
(pt)
|
2008-10-17 |
2017-12-06 |
Sanofi Aventis Deutschland |
Combinação de uma insulina e de um agonista do glp-1
|
EP2349279A4
(en)
|
2008-10-28 |
2013-12-25 |
Univ Leland Stanford Junior |
ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
|
AU2010208305A1
(en)
|
2009-01-28 |
2011-09-08 |
Smartcells, Inc. |
Synthetic conjugates and uses thereof
|
WO2010088294A1
(en)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Conjugate based systems for controlled drug delivery
|
AU2010212794A1
(en)
|
2009-02-12 |
2011-08-11 |
Proyecto De Biomedicina Cima, S.L. |
Use of cardiotrophin- 1 for the treatment of metabolic diseases
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US8623345B2
(en)
|
2009-03-20 |
2014-01-07 |
Smartcells |
Terminally-functionalized conjugates and uses thereof
|
EP2498801B1
(de)
|
2009-11-13 |
2018-01-24 |
Sanofi-Aventis Deutschland GmbH |
HARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND desPro36Exendin-4(1-39)-Lys6-NH2 UND METHIONIN
|
PL2498802T3
(pl)
|
2009-11-13 |
2015-06-30 |
Sanofi Aventis Deutschland |
Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
|
JP2013516500A
(ja)
|
2010-01-11 |
2013-05-13 |
ヒールオア・リミテッド |
炎症性疾患および障害を治療するための方法
|
CA2996757A1
(en)
*
|
2010-02-24 |
2011-09-01 |
Emisphere Technologies, Inc. |
Oral b12 therapy
|
EP2611458B1
(en)
|
2010-08-30 |
2016-09-21 |
Sanofi-Aventis Deutschland GmbH |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
WO2012041816A1
(en)
|
2010-09-30 |
2012-04-05 |
Solvay Sa |
Derivative of epichlorohydrin of natural origin
|
WO2012115641A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
|
CN105749253A
(zh)
|
2011-03-01 |
2016-07-13 |
Jds治疗有限公司 |
用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
BR112014004726A2
(pt)
|
2011-08-29 |
2017-04-04 |
Sanofi Aventis Deutschland |
combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
AU2012328407A1
(en)
|
2011-10-27 |
2014-05-22 |
Case Western Reserve University |
Ultra-concentrated rapid-acting insulin analogue formulations
|
WO2014004278A1
(en)
*
|
2012-06-26 |
2014-01-03 |
The Curators Of The University Of Missouri |
Photocleavable drug conjugates
|
WO2014015078A1
(en)
|
2012-07-17 |
2014-01-23 |
Michael Weiss |
O-linked carbohydrate-modified insulin analogues
|
EP3332810B1
(fr)
|
2012-11-13 |
2021-01-13 |
Adocia |
Formulation à action rapide d'insuline comprenant un composé anionique substitué
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
US9707275B2
(en)
|
2012-12-19 |
2017-07-18 |
Wockhardt Limited |
Stable aqueous composition comprising human insulin or an analogue or derivative thereof
|
BR112015013223A2
(pt)
|
2012-12-26 |
2017-07-11 |
Wockhardt Ltd |
composição farmacêutica
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
TW201605489A
(zh)
|
2013-10-25 |
2016-02-16 |
賽諾菲公司 |
賴谷胰島素(insulin glulisine)的穩定調配物
|
EP3185887B1
(en)
|
2014-08-26 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Method for preparing crystalline insulin or insulin analog compositions
|
EP3229828B1
(en)
|
2014-12-12 |
2023-04-05 |
Sanofi-Aventis Deutschland GmbH |
Insulin glargine/lixisenatide fixed ratio formulation
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
EP3413900A1
(en)
|
2016-02-11 |
2018-12-19 |
Nutrition 21, LLC |
Chromium containing compositions for improving health and fitness
|
JOP20190277B1
(ar)
|
2017-06-01 |
2023-09-17 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
WO2019125879A2
(en)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Conjugate based systems for controlled insulin delivery
|
US11820805B2
(en)
|
2017-12-18 |
2023-11-21 |
Merck Sharp & Dohme Llc |
Conjugate based systems for controlled insulin delivery
|
CA3157995A1
(en)
|
2019-10-25 |
2021-04-29 |
Cercacor Laboratories, Inc. |
Indicator compounds, devices comprising indicator compounds, and methods of making and using the same
|
GB2610490A
(en)
|
2020-03-31 |
2023-03-08 |
Protomer Tech Inc |
Conjugates for selective responsiveness to vicinal diols
|
TW202237188A
(zh)
|
2020-11-19 |
2022-10-01 |
美商普羅托莫科技公司 |
芳族含硼化合物及胰島素類似物
|
US20230374045A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|